Chlorhexidine (free base) structure
Find information on thousands of medical conditions and prescription drugs.

Hibiclens

Chlorhexidine Gluconate is an antiseptic used as an active ingredient in mouthwash designed to kill dental plaque and other oral bacteria. In some countries it is available by prescription only. It is sometimes marketed under the brand names Peridex, Periochip, Periogard Oral Rinse or in the UK Corsodyl or Chlorohex. Chlorhexidine Gluconate-based products are usually utilized to combat or prevent gum diseases such as gingivitis. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
Habitrol
Halcion
Haldol
Haloperidol
Halothane
Heparin sodium
Hepsera
Herceptin
Heroin
Hetacillin
Hexachlorophene
Hexal Diclac
Hexal Ranitic
Hexetidine
Hibiclens
Histidine
Hivid
HMS
Hyalgan
Hyaluronidase
Hycodan
Hycomine
Hydralazine
Hydrochlorothiazide
Hydrocodone
Hydrocortisone
Hydromorphone
Hydromox
Hydroxycarbamide
Hydroxychloroquine
Hydroxystilbamidine
Hydroxyzine
Hyoscine
Hypaque
Hytrin
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Chlorhexidine Gluconate is also used in non-dental applications, most notably under the brand name Hibiclens, to combat microbes. It is used for general skin cleansing, a surgical scrub and a pre-operative skin preparation. Due to other chemicals listed as inactive ingredients, Hibiclens is not suitable for use as mouthwash.

Known to be deactivated by fluoride, Chlorhexidine Gluconate mouth rinses should be taken at least 30 minutes after using fluoridated oral products (e.g, toothpaste and mouthwash). For best effectiveness, food, drink, and mouth rinses should be avoided for at least one hour after use. However, mouthwashes formulations containing both chlorhexidine digluconate and fluoride have been found to be effective.

Read more at Wikipedia.org


[List your site here Free!]


Community-acquired methicillin-resistant Staphylococcus aureus among military recruits
From Emerging Infectious Diseases, 5/1/04 by Craig E. Zinderman

We report an outbreak of 235 community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections among military recruits. In this unique environment, the close contact between recruits and the physical demands of training may have contributed to the spread of MRSA. Control measures included improved hygiene and aggressive clinical treatment.

**********

Methicillin-resistant Staphylococcus aureus (MRSA) was first recognized in the 1960s and has since become a well-known cause of nosocomial infections (1). Recently, MRSA has been reported with increasing frequency outside healthcare settings (2-5). Community-acquired outbreaks have been reported in a variety of populations, including prison inmates (3,4), players of contact sports (6,7), children in daycare (8), and crewmembers of a naval ship (9). These groups do not possess the risk factors traditionally associated with MRSA infection, namely, recent hospitalization, dialysis, residence in a long-term care facility, or intravenous drug use (1,2). We report an outbreak of community-acquired MRSA infections among recruits at a large military training facility in the southeastern United States.

The Study

The training facility where the outbreak occurred had a recruit population that fluctuated from 3,500 to 7,000. A case-patient was defined as a recruit with a clinically recognized skin or soft-tissue infection and a positive MRSA culture from the site of infection. Laboratory records showed that from October 2000 to July 2002, 47 culture-confirmed MRSA infections occurred among recruits (Figure 1). During this period, the monthly incidence of MRSA did not exceed two cases per 1,000 recruits (Figure 2). However, from August to December 2002, 235 MRSA cases occurred. During the outbreak period, the monthly incidence rates ranged from 4.9 to 11 cases per 1,000 recruits.

[FIGURE 2 OMITTED]

Of the case-patients, 209 (89%) were men. This percentage paralleled the overall male recruit population in 2002 (88% male). Although information on the specific age of infected recruits was not available, all recruits at this facility were 17-25 years of age. Most infections occurred on an extremity (73.7%), most commonly the lower leg (16.0%) and the knee (13.9%) (Table).

To investigate what aspects of training might be associated with transmission, cases were sorted by week of training when illness was diagnosed (Figure 3). Data on training week was available for 143 (61%) of the outbreak patients. The rise in cases during weeks 1-5 suggests that transmission increased with time in training. Of the cases, 86% occurred during weeks 6 to 12 but did not seem to be associated with any single event. Moderate increases occurred during weeks 6 and 7 (rifle range training) and week 11, which included the "crucible," a 54-hour strenuous field exercise and final test before graduation. These weeks include important milestones for recruits, and some may have delayed seeking medical care until after completing these steps.

Medical records from 20 patients were randomly selected and reviewed during the investigation. These patients included 18 men and 2 women, 17-24 years of age. The diagnoses included abscesses (15 patients), cellulitis (2 patients), and folliculitis (3 patients). The antimicrobial agents most commonly prescribed for initial treatment were dicloxacillin (6), levofloxacin (5), and ciprofloxacin (4). No patients had a history of hospitalization within the previous year, although one patient had been treated with levofloxacin for pneumonia 2 weeks before.

Nasal screening was conducted to identify carriers and determine the colonization rate among staff members permanently assigned to the training facility. Anterior nasal swabs were obtained from 874 workers who had direct contact with recruits, including medical, dental, and laboratory personnel, drill instructors, barbers, and other ancillary staff. Of these, 24 (2.7%) were colonized with MRSA.

Through interviews with healthcare providers, laboratory personnel, and recruits, investigators found that most patients did not display established risk factors for MRSA (history of chronic medical conditions, hospitalization or surgery within the previous year, history of drug use, or recent use of an antimicrobial agent). Also, the MRSA isolates were sensitive to many commonly used outpatient antimicrobial agents, including trimethoprim/sulfamethoxazole and clindamycin.

No recent lapses in recruit hygiene training or practices had occurred. Recruits were afforded daily time for showering, cleaning, and personal hygiene. However, this time was limited, perhaps leading to deficient hygiene practices among some recruits (i.e., inadequate showering, infrequent handwashing, sharing towels and other personal items).

In November 2002, facility personnel implemented an array of control measures with an emphasis on improving hygiene and treatment regimens. Based on existing recommendations for preventing MRSA transmission in healthcare settings (10), antibacterial soaps and hand sanitizers were placed at all recruit sinks, and investigators recommended that hand washing be conducted as frequently as possible. All recruits were issued personal bottles of antibacterial hand sanitizer for use when soap and water were not readily available. Daily showers of adequate duration were enforced, and sharing personal items such as towels and razors was prohibited.

In addition, local healthcare providers were alerted to the presence of MRSA among recruits. Culturing of lesions was encouraged. Patients were treated with the following regimen aimed at eliminating both MRSA infection and nasal carriage: oral rifampin and minocycline for 10 to 14 days, nasal mupirocin twice daily for 10 days, and Hibiclens washes. (Trimethoprim/sulfamethoxazole could be substituted for minocycline.) Finally, preventive medicine staff conducted biweekly surveillance for MRSA cases by using laboratory records.

The outbreak ended in December 2002, shortly after interventions were implemented. The actual number of cases as well as the incidence (cases per 1,000 recruits) declined by more than half in December 2002 and decreased further in January and February 2003 (Figures 1 and 2).

Conclusions

This large outbreak demonstrates the threat of MRSA in a close-contact environment such as recruit training. Our findings are consistent with community-acquired, rather than nosocomial, MRSA infection (1-3,6). MRSA is spread by direct contact, most often through the hands of an infected or nasally colonized person (3). Several recent community-acquired MRSA outbreaks have involved comparable close-contact environments (3,8,9). Spread of community-acquired MRSA has also been associated with prolonged physical contact between sports participants (6,7). Activities such as hand-to-hand combat training, life-saving, and team skill-building exercises involve similar physical contact between recruits.

The physical nature of recruit training is another factor that may have contributed to this outbreak. Recruits often have minor cuts or abrasions that increase the risk of developing skin infections. Such injuries would be expected during physically demanding activities such as running, hiking, and negotiating obstacle courses. Indeed, most MRSA infections occurred on exposed surfaces such as arms, legs, and knees.

The growth and transmission of methicillin-sensitive S. aureus (MSSA), and accordingly MRSA, are increased in humid environments (11). The number of cases increased during warmer months, a time when recruits have more exposed skin surfaces. This may increase their risk for superficial wounds as well as contact with other recruit's skin surfaces. Furthermore, some recruits reported that their infections started as insect bites, also a seasonal problem.

The outbreak was unlikely to have originated from a single source. Cases occurred throughout the facility and were not localized to recruits who had contact with a particular instructor or other staff member. Further, the percentage of staff members at the facility who were found to be carriers was small and consistent with the 2%-3% MRSA carriage rates found in recent studies (9,12,13). Although how much contact these carriers routinely had with recruits is unclear, this small number of patients was not likely a major factor in spreading MRSA across so many different groups of recruits. In fact, the growing prevalence of MRSA in the general population (1,2,12,14) is an important concern because recruits may enter the military already colonized.

Maintaining good hygiene and avoiding contact with open skin lesions are the primary means to prevent the spread of MRSA infections (3,7). Although no recent changes in recruit hygiene had occurred that were directly responsible for the outbreak, the hygiene deficiencies noted in some recruits combined with the increased prevalence of MRSA were important contributing factors. Control measures were instituted to improve hygiene, including frequent hand washing and the use of antibacterial hand sanitizers. Similar measures have been implemented to control MRSA outbreaks in comparable settings (3,6,7,15).

Before August 2002, healthcare providers did not routinely obtain bacterial identification and sensitivities on skin infections, possibly delaying effective treatment in some cases. Once aware that MRSA was prevalent among recruits, healthcare providers improved treatment by culturing skin lesions whenever possible and prescribing appropriate antimicrobial agents for MRSA infections. Thus, the primary interventions used were recommending improved hygiene practices for recruits and implementing aggressive clinical protocols. These control measures, along with the onset of cooler weather, likely played important roles in ending the outbreak.

This outbreak occurred in a previously healthy military training population and was associated with close contact, limited opportunity for practicing good personal hygiene, warm weather, and physical stress. Reducing MRSA infections was related to implementing interventions to improve personal hygiene, aggressive evaluation and treatment of people with soft tissue injuries and infections, and cooler weather.

Acknowledgments

We thank John Gerhard for his support and assistance with the investigation, Joyce Lapa for editorial and writing assistance, Todd May for his support and assistance with data acquisition, and Joseph Cahill for his assistance with the investigation.

References

(1.) Chambers H. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001;7:178-82.

(2.) Naimi T, LeDell K, Boxrud D, Groom A, Steward C, Johnson S, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis 2001;33:990-6.

(3.) Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison--Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001;50:919-22.

(4.) Pan E, Diep B, Carleton H, Charlebois E, Sensebaugh G, Hailer B, et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis 2003;37:1384-8.

(5.) Baggett H, Hennessy T, Leman R, Hamlin C, Bruden D, Reasonover A, et al. An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol 2003;24:397-402.

(6.) Lindenmayer J, Schoenfeld S, O'Grady R, Carney J. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Arch Intern Med 1998;158:895-9.

(7.) Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants--Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 2003;52:793-5.

(8.) Adcock P, Pastor P, Medley F, Patterson J, Murphy T. Methicillin-resistant Staphylococcus aureus in two childcare centers. J Infect Dis 1998:178:577-80.

(9.) Lamar J, Carr R, Zinderman C, McDonald K. Sentinel cases of community acquired methicillin-resistant Staphylococcus aureus onboard a Naval Ship. Mil Med 2003;168:135-8.

(10.) Centers for Disease Control and Prevention. Guideline for hand hygiene in healthcare settings: recommendations of the healthcare infection control practices advisory committee and the HICPAC/SHEA/APIC/IDSA hand hygiene task force. MMWR Recomm Rep 2002;51:1-56.

(11.) Chin J, editor. Control of communicable diseases manual. 17th ed. Baltimore: United Book Press, Inc.; 2000.

(12.) Kenner J. O'Connor T, Piantanida N, Fishbain J, Eberly B, Viscount H, et al. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 2003;24:439-44.

(13.) Jernigan J, Pullen A, Partin C. Jarvis W. Prevalence and risk factors for colonization with methicillin-resistant Staphylococcus aureus in an outpatient clinic population. Infect Control Hosp Epidemiol 2003;24:445-50.

(14.) Kallen A, Driscoll T, Thornton S, Olson P, Wallace M. Increase in community-acquired methicillin-resistant Staphylococcus aureus at a naval medical center. Infect Control Hosp Epidemiol 2000;21:223-6

(15.) Bureau of Prisons. Clinical practice guidelines for the management of methicillin resistant Staphylococcus aureus infections [accessed 2003 Nov 1]. Available from: http://nicic.org/Downloads/PDF/ 2003/019356.pdf

Dr. Zinderman is a preventive medicine officer with the U.S. Navy Environmental and Preventive Medicine Unit #2, Norfolk, Virginia. His current work involves consultation in preventive medicine, epidemiology, and deployment health for the U.S. Navy and Marine Corps.

Craig E. Zinderman, * Byron Conner, * Mark A. Malakooti, ([dagger]) James E. LaMar, * Adam Armstrong, ([double dagger]) and Bruce K. Bohnker ([dagger]) (1)

* Navy Environmental and Preventive Medicine Unit-Two, Norfolk, Virginia, USA; ([dagger]) Navy Environmental Health Center, Portsmouth, Virginia, USA; and ([double dagger]) Naval Medical Center, Portsmouth, Virginia, USA

(1) Views expressed are those of the authors and are not approved by or representative of the Bureau of Medicine and Surgery, the Department of the Navy, or the Department of Defense.

Address for correspondence: LCDR Craig E. Zinderman MC USNR, Navy Environmental and Preventive Medicine Unit-Two, 1887 Powhatan Street, Norfolk, VA 23511-3394, USA; fax: 757-444-1191: email: czinderman@nepmu2.med.navy.mil

COPYRIGHT 2004 U.S. National Center for Infectious Diseases
COPYRIGHT 2004 Gale Group

Return to Hibiclens
Home Contact Resources Exchange Links ebay